- 54.7k views
Liquid Biopsies: Revolutionizing Cancer Detection
Liquid biopsies represent a groundbreaking advancement in cancer detection, offering a non-invasive alternative to traditional tissue biopsies. These tests analyze circulating tumor DNA (ctDNA) or other biomarkers in blood to identify genetic mutations or alterations associated with cancer. Liquid biopsies provide a real-time snapshot of the tumor's genetic profile, aiding in early cancer detection, monitoring treatment response, and detecting minimal residual disease. This revolutionary approach holds promise for personalized medicine, allowing for more precise and timely interventions, ultimately transforming the landscape of cancer diagnosis and management.
About the Speaker

Dr. Srinath Bharadwaj
Consultant, Medical Oncology and Haematology, Apollo Cancer Institutes, Jubilee Hills, Hyderabad
Dr. Srinath Bharadwaj R is a medical oncologist and hematologist currently working as a consultant at Apollo Cancer Institutes in Hyderabad, Telangana. He has extensive academic qualifications, including a DM in Medical Oncology and an MD in Radiation Oncology.